Skip to main content
. 2019 Sep 12;10(9):678. doi: 10.1038/s41419-019-1909-2

Fig. 1. The flow diagram of experimental design.

Fig. 1

a The flow diagram of experimental design of human part which is to demonstrate the increased NETs, the activation of mDCs, and the enhanced Th1/Th17 cell responses in COPD patients; NETs promote mDCs activation and Th1/Th17 differentiation; Erythromycin inhibits NETs in human vitro. PMN polymorphonuclear neutrophil, NETs neutrophil extracellular traps, NE neutrophil elastase, MPO myeloperoxidase, CITH3 citrullinated histone H3, mDCs myeloid dendritic cells, Th1 Helper T lymphocytes 1, Th17 Helper T lymphocytes 17. b The flow diagram of experimental design of animal part which is to demonstrate that erythromycin inhibits NETs and attenuates the activation of mDCs and Th1/Th17 cell responses in a murine model of emphysema in vivo. BALF bronchoalveolar lavage fluid, CITH3, citrullinated histone H3